Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06180902Not ApplicableRecruiting

Comparing Fluid Responsiveness Assessment Methods in Patients With Impaired Consciousness

Role: lead

NCT07070050Phase 4Recruiting

Continuous vs. Bolus Administration of NSAIDs After Laparoscopic Surgery for Multimodal Analgesia

Role: lead

NCT06545786Recruiting

Intraoperative Diagnosis of Neurocognitive Complications Via Electroencephalographic Analysis

Role: lead

NCT06545838Recruiting

Renin Levels as Prognostic Indicators of Septic Shock Severity and Outcome

Role: lead

NCT06545825Completed

Effects of Prolonged and Chronic Critical Illness Induced by Brain Injury on Metabolic State

Role: lead

NCT04921436Not ApplicableCompleted

Modulation of Microbiota Metabolism in Cardiac Surgery Patients

Role: collaborator

All 6 trials loaded